California puts the diversion duty on the pharmacy as an entity as well as on the individual: the Business and Professions Code requires written procedures for licensed staff who are impaired or suspected of diverting, sets a 14-day clock for reporting them to the Board of Pharmacy, and the Board's regulations add loss reporting and inventory reconciliation. The Health and Safety Code defines the criminal offences and the CURES monitoring programme. Each statement below links to the text it comes from.

Statutes: pharmacy procedures, unprofessional conduct and controlled-substance offences

Business and Professions Code section 4104 is the core diversion provision for pharmacies. Every pharmacy must have in place procedures for taking action to protect the public when a licensed individual employed by or with the pharmacy is discovered or known to be chemically, mentally or physically impaired to the extent it affects practice, or to have engaged in the theft, diversion or self-use of dangerous drugs, and must have written policies and procedures for addressing those situations [1].

Section 4301 lists unprofessional conduct, for which the Board must take action against a licence holder. The list includes the commission of any act involving moral turpitude, dishonesty, fraud, deceit or corruption; administering to oneself any controlled substance, or using a dangerous drug or alcohol to the extent that it impairs the ability to practise safely; and violating the statutes of California, any other state or the United States regulating controlled substances and dangerous drugs [2]. It also lists the conviction of a crime substantially related to the duties of a licensee, and provides that a record of conviction of a federal controlled-substances offence or a California statute regulating controlled substances or dangerous drugs is conclusive evidence of unprofessional conduct [2].

Health and Safety Code section 11173 contains the offences most closely tied to obtaining drugs by deception. No person may obtain or attempt to obtain controlled substances, or procure a prescription for them, by fraud, deceit, misrepresentation or subterfuge or by concealing a material fact, make a false statement in any prescription, order, report or record required by the division, or affix a false or forged label to a package containing controlled substances [3].

Board regulations: loss reporting and inventory reconciliation

Title 16 California Code of Regulations section 1715.6 sets the content and timing of loss reports. The owner must submit a report to the Board no later than 30 days after discovery of specified losses, and those include any loss of a controlled substance, regardless of amount, that is attributed to employee theft, in addition to the reporting requirements and time frames in Business and Professions Code section 4104 [4]. The reportable categories also include aggregate unreported losses discovered over the preceding year that reach 99 dosage units of tablets, capsules or other oral medication, 10 dosage units of single-dose injectables, lozenges, films, suppositories or patches, or two or more multi-dose containers, and any other significant loss as determined by the pharmacist-in-charge [4].

Section 1715.65 requires periodic inventory activities and reconciliation reports to detect and prevent the loss of federal controlled substances. Reconciliation reports for federal Schedule II controlled substances must be prepared at least once every three months, and the section lists specific products and strengths, beginning with alprazolam at 1 and 2 milligrams per unit and tramadol at 50 milligrams per unit, that must be reconciled at least once every 12 months [5].

A reportable loss under the Board's rules also triggers a reconciliation duty: the pharmacist-in-charge defines patterns of loss under the pharmacy's policies and procedures, and a reportable loss requires an inventory reconciliation report for each pattern identified [5]. In practice the two regulations work together, with the reconciliation report supplying the facts the loss report must contain.

Penalties: licence discipline and criminal exposure

Section 4300 states that every licence issued by the Board may be suspended or revoked. After a hearing or default, the Board may discipline a licence holder by suspending judgment, placing the holder on probation, suspending the right to practise for a period not exceeding one year, revoking the licence, or taking any other action it considers proper [6]. The Board may also refuse a licence to an applicant guilty of unprofessional conduct, and may issue a probationary licence in its discretion [6].

Discipline can also reach the pharmacy itself. Section 4104 imposes its duties directly on every pharmacy, and section 4301 lists as unprofessional conduct violating or attempting to violate any provision of the pharmacy chapter or of the applicable federal and state laws and regulations governing pharmacy [1] [2].

Criminal penalties sit in the Health and Safety Code. For example, section 11350(a) provides that a person who possesses a specified controlled substance, including a Schedule III, IV or V narcotic drug, without the written prescription of a licensed physician, dentist, podiatrist or veterinarian is punished by imprisonment in a county jail for not more than one year, with a different sentencing provision for people with certain prior convictions [7]. A judge may also assess a fine not to exceed $70 in addition to that punishment [7]. Other offences, including the section 11173 fraud offences, carry penalties set elsewhere in the code that this page does not summarise.

Reporting duties and deadlines

California has more than one reporting clock, and the shorter one applies to diversion by staff. Under section 4104, a pharmacy must report to the Board, within 14 days of the receipt or development of the information, any admission by a licensed individual of impairment or of theft, diversion or self-use of dangerous drugs, any video or documentary evidence of such conduct, and any termination of a licensed individual based on it [1].

The report must contain enough detail to inform the Board of the facts, including an estimate of the type and quantity of all dangerous drugs involved, the timeframe over which losses are suspected and the date of the last controlled-substances inventory, and the Board may require the pharmacy to prepare and submit an audit of the drugs suspected to be missing [1]. Anyone making a report that the section authorises or requires has immunity from civil or criminal liability that might otherwise arise from making it [1].

The general loss report under regulation 1715.6 runs to 30 days from discovery, and it must specify the identity, amount and strength of each controlled substance lost and the date of discovery [4]. Regulation 1715.65 adds that a pharmacy or clinic must report in writing identified losses and known causes within 30 days of discovery unless the cause is theft, diversion or self-use, in which case the report is due within 14 days of discovery [5]. Dispensing data have a separate clock: dispensers report to the Department of Justice not more than one working day after a controlled substance is released to the patient, when reporting under Health and Safety Code section 11165(d) [8].

Monitoring: CURES and the pharmacists recovery programme

CURES is California's prescription drug monitoring programme. The Attorney General's office states that Health and Safety Code section 11165.1 requires licensed health care practitioners authorised to prescribe Schedule II to V controlled substances to register for access to CURES, and that California licensed pharmacists must register for access on issuance of a pharmacist licence [8]. Section 11165.1 itself provides that a pharmacist must, on licensure, submit an application to obtain approval to access electronically the controlled-substance history of a patient [9].

The mandatory consultation duty is set out in section 11165.4, which the Attorney General's page identifies as the source of the requirement to consult CURES [8]. The page directs readers to their licensing board for the details of the consultation requirement, and this page does not restate them.

For licensees whose impairment is the issue rather than theft, the Board operates a pharmacists recovery programme. Section 4360 requires the Board to operate a programme to rehabilitate pharmacists and intern pharmacists whose competency may be impaired by abuse of alcohol, drug use or mental illness, with the intent of returning them to practice in a manner that will not endanger public health and safety [10]. A pharmacist who voluntarily enters is not subject to discipline solely on that entry, unless they would pose a threat to public health and safety, although information about their conduct that reaches the Board from other sources may still serve as a basis for discipline [10].

Sources

Each link below was fetched on 15 November 2026 and returned HTTP 200. Bracketed numbers in the text open the same pages.

  1. Cal. Bus. & Prof. Code § 4104, Licensed Employee, Theft or Impairment: Pharmacy Procedures (Board of Pharmacy law book, July 2026 edition, pp. 114-115)
  2. Cal. Bus. & Prof. Code § 4301, Unprofessional Conduct (Board of Pharmacy law book, July 2026 edition, pp. 262-264)
  3. Cal. Health & Safety Code § 11173, Fraud, Deceit, Misrepresentation or False Statement
  4. 16 Cal. Code Regs. § 1715.6, Reporting Drug Loss (Board of Pharmacy law book, July 2026 edition, pp. 443-444)
  5. 16 Cal. Code Regs. § 1715.65, Inventory Activities and Reconciliation Reports of Controlled Substances (Board of Pharmacy law book, July 2026 edition, pp. 444-446)
  6. Cal. Bus. & Prof. Code § 4300, Revocation and Suspension (Board of Pharmacy law book, July 2026 edition, p. 260)
  7. Cal. Health & Safety Code § 11350, Possession of controlled substances formerly classified as narcotics
  8. California Attorney General, CURES (Controlled Substance Utilization Review and Evaluation System)
  9. Cal. Health & Safety Code § 11165.1, CURES access applications
  10. Cal. Bus. & Prof. Code §§ 4360-4362, Pharmacists Recovery Program (Board of Pharmacy law book, July 2026 edition, pp. 297-298)

Scope. This page summarises statutes and regulations as read in November 2026 and is not legal advice. It does not cover the Board of Registered Nursing, medical or osteopathic boards, federal DEA requirements, or the criminal penalties attached to every Health and Safety Code offence. The legislature's own code site returns an access error to automated checks, so statute text is read from the Board of Pharmacy's published law book and a public reproduction of the Health and Safety Code.

Related pages

Would your controls meet these duties?

The free self-assessment scores your own controls: 7 sections, 45 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.

Start the free assessment

Would your controls meet these duties?

The free self-assessment scores your own controls: 7 sections, 45 weighted items, a score for each section, and a PDF you can take to your committee. No account or login.

Start the free assessment